Table 7.
Pelvic floor dysfunction symptoms of the study population at follow up.
| SSLS-A (n = 75) | VPP (n = 61) | p Value | |
|---|---|---|---|
| Bulge symptoms, n (%) | 15 (20) | 1 (1.6) | 0.001 |
| Occult stress urinary incontinence, n (%) | 11/50 (22) | 11/37 (29.7) | 0.41 |
| Persisting stress urinary incontinence, n (%) | 7/25 (28) | 8/24 (33.3) | 0.68 |
| New onset urgency urinary incontinence, n (%) | 3/43 (6.9) | 8/47 (17) | 0.15 |
| Persisting urgency urinary incontinence, n (%) | 8/32 (25) | 3/14 (21.4) | 0.79 |
| New onset voiding urinary symptoms, n (%) | 3/51 (5.9) | 1/33 (3) | 0.64 |
| Persisting voiding urinary symptoms, n (%) | 4/24 (16.7) | 1/28 (3.6) | 0.16 |
SSLS-A: anterior sacrospinous ligament suspension; VPP: vaginal patch plastron.